What is the recommended dose of risperidone (atypical antipsychotic) for infants?

Risperidone Dosing for Infants

Risperidone is not FDA-approved for infants, and there is extremely limited safety and efficacy data in this age group; however, when clinically necessary for severe behavioral disturbances in infants ≤2 years, the available evidence suggests starting doses of 0.1-0.25 mg daily (0.01-0.04 mg/kg/day) administered once daily. 1

Critical Context and Limitations

• The FDA label does not provide dosing recommendations for infants, as risperidone is only FDA-approved for children ≥5 years for autism-related irritability, adolescents ≥13 years for schizophrenia, and pediatric patients ≥10 years for bipolar mania 2
• The American Academy of Child and Adolescent Psychiatry guidelines focus on children aged 5-17 years, with weight-based dosing of 0.02-0.06 mg/kg/day for children 5-12 years 3
• Use in infants represents off-label prescribing and should only be considered when potential benefits clearly outweigh risks 4, 3

Available Evidence for Infants

Dosing Strategy from ICU Delirium Study

The largest cohort describing risperidone use in infants ≤2 years (n=17) found: 1

• Initial daily dose: 0.1-0.25 mg (0.01-0.04 mg/kg) 1
• Dosing frequency: Once daily in 76.5% of patients 1
• Dose titration: More than 80% required dose increases during therapy 1
• Safety profile: No adverse events leading to discontinuation were reported 1

Preschool Data (Ages 3-6 Years)

For context, studies in slightly older preschool children (ages 3-6 years) used: 5, 6

• Optimal dose: 0.5 mg/day in children aged 3.6-6.6 years 6
• Dose range: 0.75-2.5 mg daily in young children with mood disorders 7
• Risperidone was well tolerated over 6 months with weight gain and hypersalivation as most common side effects 5

Practical Dosing Algorithm for Infants

When risperidone use is deemed medically necessary in infants:

1. Start at 0.1 mg once daily (approximately 0.01-0.02 mg/kg/day) 1
2. Assess response after minimum 4 days before any dose adjustment 2
3. If inadequate response, increase by 0.05-0.1 mg increments 1
4. Maximum studied dose in infants ≤2 years: 0.25 mg daily 1
5. Consider twice-daily dosing only if once-daily causes excessive peak sedation 1

Critical Safety Monitoring

Children with intellectual disability may be more sensitive to side effects, requiring even more conservative dosing 4, 3

Baseline Assessment Required:

• Weight, height, and BMI 3, 8
• Metabolic parameters (glucose, lipids) 3, 8
• Blood pressure 8
• Prolactin levels 3, 8

Ongoing Monitoring:

• Weight at each visit during first 3 months, then monthly 8
• Metabolic parameters at 3 months, then annually 8
• Clinical assessment for extrapyramidal symptoms at each visit 8, 9
• Monitor for somnolence (occurs in 51-63% of pediatric patients) 9

Common Pitfalls and Warnings

Avoid these critical errors:

• Do not use adult or older pediatric dosing algorithms in infants - the dose per kilogram is substantially lower in infants 1
• Do not escalate doses rapidly - more than 80% of infants required dose increases, but this should occur gradually 1
• Weight gain is extremely common (36-52% in pediatric patients) and may be more problematic in developing infants 3, 9
• Extrapyramidal symptoms can occur even at low doses - risperidone causes more EPS than other atypical antipsychotics 9
• Hyperprolactinemia occurs frequently but is usually asymptomatic 4, 9

When to Avoid Risperidone in Infants

Do not use risperidone if:

• Medical causes of behavioral disturbance have not been ruled out (pain, metabolic issues, sleep disorders) 3, 8
• Behavioral interventions have not been attempted first 3, 8
• The infant has cardiac risk factors without ECG monitoring 9
• There is pre-existing hepatic dysfunction 9